Physician profile
Michael James Chen
NPI 1629431853
$13,647.35
in general payments reported to CMS, 2019-2025
10 companies · $9,107 in 2025
The $9,107 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2022: $3,993 · 2023: $353 · 2024: $19.04 · 2025: $9,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,960 · Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,960.00 |
| Food and Beverage | $519.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $8,960.00 | 2025 | |
| Elevate Surgical Co | $2,400.00 | 2022 | |
| Summit Surgical Corp. | $1,200.00 | 2022 | |
| Depuy Synthes Sales INC. | $330.97 | 2021-2023 | Na |
| Si-Bone, INC. | $226.48 | 2023-2025 | |
| Nuvasive Specialized Orthopedics, INC. | $181.93 | 2022 | |
| Stryker Corporation | $172.16 | 2021-2025 | Aequalis Perform, Aequalis Flex Revive, Aequalis Perform Reversed |
| Amgen INC. | $129.41 | 2022 | |
| My01 INC. | $27.36 | 2025 | My01 Continuous Compartmental Pressure Monitor |
| Solventum Corporation | $19.04 | 2024 | Prevena, V.A.C. Dermatac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.